Self-Paced Course: Molecular Biology Techniques 2024

Self-Paced Course: Molecular Biology Techniques 2024
Go back

Overview

The application and development of molecular biology techniques are essential for new discoveries in the life sciences. The self-paced course “Molecular Biology Techniques: Comprehensive Approaches for Educators and Enthusiasts“, organised by EMBL’s Science Education and Public Engagement team in partnership with Merck, provides an insight into the key molecular biology techniques used in modern research and explores their effective teaching methods in the classroom.

This free online course will run from 21 October to 1 December 2024. Participants can join at any time and progress through the course material at their convenience. No live or Q&A sessions are intended. Upon completion, participants can earn a certificate of attendance by completing a short feedback questionnaire.

Dates                         Duration                    Weekly study                Format

21 Oct – 1 Dec              6 weeks                        2 hours                        100% online    

Please note: This course reuses content from the 2021 EMBL virtual LearningLAB “Taking a Fresh Look: Teaching Molecular Biology Techniques in the Classroom“.  In addition to the previous content, pre-recorded Zoom scientific discussions and new learning and teaching resources have been added.

Who is this course for?
This course is designed for formal and informal educators, including teacher trainers and educators in training. It is also suitable for science professionals and anyone interested in learning more about molecular biology techniques.

register now

Our latest News

discover more
Green hydrogen for a climate-neutral industry: InnovationLab organizes Clean Tech Innovation Day

Green hydrogen for a climate-neutral industry: InnovationLab organizes Clean Tech Innovation Day

Heidelberg, Germany, November 6, 2024 – The technology transfer platform InnovationLab is looking forward to the premiere of a new event format: hydrogen experts from Germany and abroad are expected to attend the Clean Tech Innovation Day on Monday, November 11 (9 a.m. to 6 p.m.). Together with its two co-partners, the Rhine-Neckar metropolitan region […]

read more
New findings on cell types and their interactions in multiple sclerosis

New findings on cell types and their interactions in multiple sclerosis

An international research team led by Professor Dr. Lucas Schirmer and Professor Dr. Julio Saez-Rodriguez from the Medical Faculties of Heidelberg University, in Mannheim and Heidelberg, has studied the different cell types in so-called subcortical lesions, tissue damage to deep brain structures, at different stages of multiple sclerosis (MS) and investigated how they communicate. In […]

read more
AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics

AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics

Partnership to Combine AbbVie’s Oncology Expertise with EvolveImmune’s Proprietary EVOLVE T-Cell Engager Platform to Develop Novel Multispecific Therapeutic Antibodies for Cancer NORTH CHICAGO, Ill. and BRANFORD, Conn., Oct. 31, 2024 /PRNewswire/ — AbbVie (NYSE: ABBV) and EvolveImmune Therapeutics, an immuno-oncology company developing next-generation biotherapeutics to overcome the therapeutic challenges of cancer cell resistance to current immunotherapies, today announced a collaboration […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp